Current Issue


Diabetes groups update standards for self-management

The 2017 revision from the American Diabetes Association and the American Association of Diabetes Educators offers recommendations on both diabetes self-management support and education.

Metformin appears to prevent type 2 diabetes, study indicates

Results from the Diabetes Prevention Program Outcomes Study also showed that metformin was cost-effective compared to placebo for patients at high risk of diabetes.

Cardiovascular disease and mortality appear lower in patients on SGLT2 inhibitors

The observational analysis compared sodium-glucose co-transporter-2 (SGLT2) inhibitors with other glucose-lowering drugs in patients with type 2 diabetes in Denmark, Norway, and Sweden.

MKSAP Quiz: Preventing diabetes

This month's quiz asks readers to advise a 49-year-old man with a strong family history of type 2 diabetes on ways to prevent development of the disease.

Spotlight on glycemic variability

Studies published in July looked at factors and conditions associated with variation in glycemic control between clinic visits, including diabetes treatment intensity and Alzheimer's disease.

Review: Dapagliflozin increases, and empagliflozin reduces, adverse renal events in type 2 diabetes

A commentary called for the findings to be confirmed with randomized controlled trials designed specifically to evaluate the effect of SGLT2 inhibitors on the kidneys.